The D stereoisomer of serine, used as a co-agonist alongside glutamate at NMDA receptors — the "second key" that, together with glutamate, unlocks the receptor behind learning and memory. Its function illustrates how the D and L forms of an amino acid can play different biological roles.
Chemical Class
D-amino acid (stereoisomer of L-serine)
Source
Brain cells, from L-serine via serine racemase; cellular sources remain debated
Made locally in the brain: the enzyme serine racemase converts the common protein-building L-serine into D-serine.
The relative contributions of astrocytes and neurons remain debated. Experiments in adult mouse and human forebrain found D-serine predominantly in neurons; mouse experiments also support astrocytic L-serine supply to neurons.
Cleared by the flavoenzyme D-amino acid oxidase and by transport, keeping synaptic D-serine tightly coupled to local demand.
Mechanism of Action
The NMDA receptor requires two simultaneous inputs: glutamate at its main site and a co-agonist at its glycine site. D-serine is often that co-agonist in synapses of the hippocampus and forebrain. Only when both sites are occupied and the postsynaptic cell is already depolarized does the channel open to let calcium in — the coincidence-detector step underlying synaptic plasticity.
Physiological Effects
Long-term potentiation: gates the Ca²⁺ signals that strengthen active synapses — the cellular substrate of learning and memory.
Development: shapes cortical circuit wiring through NMDA-dependent refinement.
Neurotransmission tuning: because D-serine availability can saturate the glycine site, it can be the rate-limiting factor in how strongly a synapse can potentiate.
Shares NMDA co-agonist duty with glycine; which of the two dominates depends on brain region and cell type.
Its parent compound L-serine feeds the one-carbon metabolic network that supplies methyl groups throughout the brain.
When It Goes Wrong
Too little D-serine may weaken NMDA-dependent cognition — a hypothesis explored in schizophrenia, where D-serine supplementation has been trialed as an adjunct therapy.
Excess NMDA receptor activation can contribute to excitotoxic injury; the contribution of D-serine depends on the experimental context.
Interpretation depends on context: altered co-agonist supply can affect plasticity, but a change in one experimental model does not establish a single cause for a human neurodegenerative disorder.